Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Fiorini

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
European Journal of Gastroenterology & Hepatology|February 27, 2026
Accuracy of a new innovative column-free miniaturized gas-mass spectrometer compared with a classic gas-mass spectrometer to diagnose and monitor Helicobacter pylori infection: a prospective single blind studyMatteo Pavoni, Marco Tartagni, Raffaele Correale, et al.
Cancers|November 13, 2025
Expanding Cancer Prevention: Strategies Integrated into Occupational Health SurveillanceGiulia Collatuzzo, Alessandro Godono, Giulia Fiorini, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
United European Gastroenterology Journal|December 24, 2022
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori managementLuigi Gatta, Olga P Nyssen, Giulia Fiorini, et al.
Journal of Clinical Medicine|March 25, 2022
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ilaria Maria Saracino, et al.
Minerva Gastroenterology|March 1, 2023
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndromeGiulia Fiorini, Ilaria M Saracino, Matteo Pavoni, et al.
Plos One|November 3, 2025
Cancer Prevention at Work (CPW) project: Rationale, framework and research protocolMagdalena Kostrzewa, Monireh Sadat Seyyedsalehi, Alessandro Godono, et al.
The American Journal of Gastroenterology|November 20, 2023
Effectiveness of Helicobacter pylori Treatments According to Antibiotic ResistanceLuis Bujanda, Olga P Nyssen, June Ramos, et al.
Gut|September 22, 2020
European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patientsOlga P Nyssen, Dmitry Bordin, Bojan Tepes, et al.
Helicobacter|July 13, 2024
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)Samuel J Martínez-Domínguez, Olga P Nyssen, Ángel Lanas, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Gastroenterology & Hepatology|February 27, 2026
Accuracy of a new innovative column-free miniaturized gas-mass spectrometer compared with a classic gas-mass spectrometer to diagnose and monitor Helicobacter pylori infection: a prospective single blind studyMatteo Pavoni, Marco Tartagni, Raffaele Correale, et al.
Cancers|November 13, 2025
Expanding Cancer Prevention: Strategies Integrated into Occupational Health SurveillanceGiulia Collatuzzo, Alessandro Godono, Giulia Fiorini, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
United European Gastroenterology Journal|December 24, 2022
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori managementLuigi Gatta, Olga P Nyssen, Giulia Fiorini, et al.
Journal of Clinical Medicine|March 25, 2022
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ilaria Maria Saracino, et al.
Minerva Gastroenterology|March 1, 2023
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndromeGiulia Fiorini, Ilaria M Saracino, Matteo Pavoni, et al.
Plos One|November 3, 2025
Cancer Prevention at Work (CPW) project: Rationale, framework and research protocolMagdalena Kostrzewa, Monireh Sadat Seyyedsalehi, Alessandro Godono, et al.
The American Journal of Gastroenterology|November 20, 2023
Effectiveness of Helicobacter pylori Treatments According to Antibiotic ResistanceLuis Bujanda, Olga P Nyssen, June Ramos, et al.
Gut|September 22, 2020
European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patientsOlga P Nyssen, Dmitry Bordin, Bojan Tepes, et al.
Helicobacter|July 13, 2024
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)Samuel J Martínez-Domínguez, Olga P Nyssen, Ángel Lanas, et al.
Pageof 9